Saud Balelah

ORCID: 0000-0001-8971-5237
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Dietary Effects on Health
  • Optimism, Hope, and Well-being
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Trypanosoma species research and implications
  • Lysosomal Storage Disorders Research
  • Carbohydrate Chemistry and Synthesis
  • Platelet Disorders and Treatments
  • Long-Term Effects of COVID-19
  • Dialysis and Renal Disease Management
  • Hemophilia Treatment and Research
  • Erythropoietin and Anemia Treatment
  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 Clinical Research Studies

King Abdulaziz Medical City
2023

King Fahad Hospital Jeddah
2020-2022

King Fahad Specialist Hospital
2020

To present the interim findings from a national study investigating safety and efficacy of convalescent plasma (CP) containing detectable IgG antibodies as treatment strategy for severe coronavirus disease 2019 (COVID-19).An open label, two-arm, phase-II clinical trial conducted across 22 hospitals Saudi Arabia. The intervention group included 40 adults (aged ≥18 years) with confirmed COVID-19 control 124 patients matched using propensity score age, gender, intubation status, history...

10.4103/sjmms.sjmms_731_20 article EN cc-by-nc-sa Saudi Journal of Medicine and Medical Sciences 2020-12-26

Abstract Fasting Ramadan is known to influence patients’ medication adherence. Data on behavior oral anticoagulant (OAC) drug intake during missing. We aimed determine patient-guided modifications of OAC regimen and evaluate its consequences. A multicenter cross-sectional study conducted in Saudi Arabia. were collected shortly after 2019. Participants patients who fasted long-term anticoagulation. Patient-guided changes comparison the regular schedule before recorded. Modification was...

10.1007/s11239-020-02218-0 article EN cc-by Journal of Thrombosis and Thrombolysis 2020-07-14

Gaucher disease (GD) is a lysosomal storage disorder that occurs due to an inherited inborn error of metabolism. GD manifested the deficient activity glucocerebrosidase enzyme results in accumulation harmful glucocerebrosides glycolipids different body cells. There are three main types differ from each other their clinical presentations. Type I characterized by absence any neurological involvement, unlike II and III. Patients with can be presented visceral manifestations (including...

10.4103/joah.joah_79_21 article EN cc-by-nc-sa Journal of Applied Hematology 2021-07-01
Coming Soon ...